CYTOKINETICS INCORPORATED - COMMON STOCK
47.37
08-January-25 16:45:00
15 minutes delayed
Stocks
-1.14
-2.35%
Today's range
47.19 - 48.49
ISIN
N/A
Source
NASDAQ
-
Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting
30 Sep 2024 09:20:00 By Nasdaq GlobeNewswire
-
Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions
27 Sep 2024 11:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Call for Proposals for Its Seventh Annual Communications Grant Program
24 Sep 2024 07:30:00 By Nasdaq GlobeNewswire
-
19 Sep 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Data From Phase 1 Study of CK-4021586
09 Sep 2024 07:30:00 By Nasdaq GlobeNewswire
-
05 Sep 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Sep 2024 16:00:00 By Nasdaq GlobeNewswire
-
01 Sep 2024 04:27:00 By Nasdaq GlobeNewswire
-
01 Sep 2024 03:51:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Participate in September Investor Conferences
29 Aug 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Reports Second Quarter 2024 Financial Results
08 Aug 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
01 Aug 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Call for Proposals for Corporate Giving Program
30 Jul 2024 07:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Announce Second Quarter Results on August 8, 2024
25 Jul 2024 16:00:00 By Nasdaq GlobeNewswire
-
16 Jul 2024 07:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
03 Jul 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants
17 Jun 2024 07:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Jun 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Participate in June Investor Conferences
29 May 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Closing of Public Offering of Common Stock
28 May 2024 16:00:00 By Nasdaq GlobeNewswire